Robbins Hilary A, Engels Eric A, Pfeiffer Ruth M, Shiels Meredith S
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (HAR, EAE, RMP, MSS).Current affiliation: HAR is currently affiliated with the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
J Natl Cancer Inst. 2015 Jan 31;107(3). doi: 10.1093/jnci/dju489. Print 2015 Mar.
Younger ages at diagnosis for blacks compared with whites have been reported for several cancer types. However, the US black population is younger than the white population, which may bias age comparisons that do not account for the populations at risk.
We analyzed Surveillance, Epidemiology, and End Results data for non-Hispanic blacks and non-Hispanic whites from 18 regions for the year 2010. We calculated crude mean ages at diagnosis among cases of 29 cancer types for whites and blacks. Separately, we calculated adjusted means that corrected for differences in population structure, which we obtained by fitting linear regression models to the ages at diagnosis with statistical weights specific to age and sex. Negative differences indicate younger ages in blacks, while positive differences indicate older ages in blacks. All statistical tests were two-sided.
Based on crude means, blacks were diagnosed at younger ages than whites for nearly every cancer type. However, adjustment for population structure shifted the comparisons toward older ages among blacks, and only six statistically significant differences of three or more years remained. Blacks were younger than whites at diagnosis for Kaposi sarcoma (-10.2 years), male soft tissue cancer (-5.6), male anal cancer (-5.5), and non-Hodgkin's lymphoma (-3.7), but older for cervical cancer (+4.7 years) and female thyroid cancer (+3.3). Smaller differences (<3 years) were present for female breast, female colon, lung, pancreas, prostate, and uterine corpus cancers (all P ≤ .001).
Most differences between blacks and whites in the age at cancer diagnosis are small. Large differences for a few cancer types may be driven by etiologic and subtype heterogeneity as well as disparities in access to care.
据报道,在几种癌症类型中,黑人的诊断年龄比白人小。然而,美国黑人人口比白人人口年轻,这可能会使未考虑到高危人群的年龄比较产生偏差。
我们分析了2010年来自18个地区的非西班牙裔黑人和非西班牙裔白人的监测、流行病学和最终结果数据。我们计算了29种癌症类型的白人及黑人病例的粗诊断平均年龄。另外,我们计算了校正人口结构差异后的调整均值,这是通过将线性回归模型拟合到诊断年龄并使用特定于年龄和性别的统计权重而获得的。负差异表明黑人年龄较小,而正差异表明黑人年龄较大。所有统计检验均为双侧检验。
基于粗均值,几乎每种癌症类型中黑人的诊断年龄都比白人小。然而,对人口结构进行调整后,黑人的年龄比较向更大年龄偏移,仅剩下6个具有统计学意义的三年或更长时间的差异。卡波西肉瘤(-10.2岁)、男性软组织癌(-5.6岁)、男性肛门癌(-5.5岁)和非霍奇金淋巴瘤(-3.7岁)诊断时黑人比白人年轻,但宫颈癌(+4.7岁)和女性甲状腺癌(+3.3岁)诊断时黑人比白人年龄大。女性乳腺癌、女性结肠癌、肺癌、胰腺癌、前列腺癌和子宫体癌的差异较小(<3岁)(所有P≤0.001)。
黑人和白人在癌症诊断年龄上的大多数差异较小。少数癌症类型的较大差异可能是由病因和亚型异质性以及医疗服务可及性差异所驱动的。